Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of a Rapid Access Platform for Investigational Drugs (RAPID) in Advanced Cancers

NCT02646319 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02646319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02646319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of a Rapid Access Platform for Investigational Drugs (RAPID) in Advanced Cancers
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2016
Completion date
April 24, 2018
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant neoplasm, cervical squamous cell carcinoma, endometrial carcinoma, malignant uterine neoplasm, recurrent bladder carcinoma, recurrent breast carcinoma, recurrent cervical carcinoma, recurrent head and neck carcinoma, recurrent malignant neoplasm, recurrent ovarian carcinoma, recurrent prostate carcinoma, recurrent renal cell carcinoma, solid neoplasm, stage iii bladder cancer, stage iii prostate cancer, stage iii renal cell cancer, stage iiia breast cancer, stage iiia cervical cancer, stage iiia ovarian cancer, stage iiib breast cancer, stage iiib cervical cancer, stage iiib ovarian cancer, stage iiic breast cancer, stage iiic ovarian cancer, stage iv breast cancer, stage iv ovarian cancer, stage iv prostate cancer, stage iv renal cell cancer, stage iva bladder cancer, stage iva cervical cancer, stage ivb bladder cancer, stage ivb cervical cancer